New Delhi: Around 32% of the world’s adult population suffer from high blood pressure today. In India, 1 in 3 people is a patient with high blood pressure. This is the reason why the demand for antihypertensive drugs is constantly increasing. There are several types of side effects in existing medicines that lower blood pressure. Because of this, the pressure to find new antihypertensive drugs is constantly increasing.
This medication will lower your blood pressure
Scientists from the pharmacy department of Banasthali Vidyapith have discovered a new antihypertensive drug that will lower blood pressure in the future. This will also help treat angina and other heart conditions. This research was published in the prestigious American Chemical Society Journal in August 2020.
Also Read: These Infallible Sattu Benefits Will Surprise You, From Diabetes To Obesity
Medicine made with computer software
Prof. Head of the Department of Pharmacy at Banasthali University. Investigations by Sarvesh Paliwal and his team members Dr. Swapnil Sharma and Dr. Seema Kesar found that this drug inhibits an enzyme called an enzyme (RHO kinase). The enzyme ROCK (RHO kinase) is an important cause of high blood pressure in humans. This drug shows its effects on rock enzyme 2. It is noteworthy and important that only one drug of this class is Fasudil, which is available in Japan (Japan) and China (China). He also holds the patent rights for this drug. Hence, this research has particular relevance in the context of India and other parts of the world. Professional. According to Paliwal, Computer Aided Drug Design (CADD) technology played a very important role in the discovery of this drug. CADD is a computer technique in which new drugs can be discovered using various computer software programs.
Also read: Do you feel physically weak? These 5 things must be included in the diet
5 years of research
Professional. Paliwal said this research started 5 years ago and was successful after testing about 3 lakh samples. After testing on mice, it was found that this drug could be viewed as an alternative to high blood pressure drugs in the future. Professional. According to Paliwal, Vice Chancellor, Vice Chancellor of Banasthali Vidyapith, Prof. Aditya Shastri has made an unprecedented contribution. He continuously encouraged team members to do this research.
Banasthali Vidyapith scientists started the clinical trial process following the success of this research.
Click here to read more health-related articles